FUL Stock Is Riding Medical, Aerospace and Pricing Trends
FUL is tapping medical, aerospace and pricing trends to support margins, but volume weakness still clouds its path to stronger growth.
Zacks Investment Research7/9/2026Neutral
FUL
H B Fuller CompanyNYSEBASIC MATERIALSSPECIALTY CHEMICALS
Key Statistics
Market Cap
$2.97B
P/E Ratio
17.09
EPS
$3.23
Beta
0.97
52W High
$68.35
52W Low
$48.51
50-Day MA
$60.75
200-Day MA
$60.35
Dividend Yield
1.65%
Profit Margin
5.30%
Forward P/E
11.92
PEG Ratio
2.20
About H B Fuller Company
HB Fuller Company formulates, manufactures and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives and other specialty chemicals worldwide. The company is headquartered in Saint Paul, Minnesota.
Fundamentals
| Revenue (TTM) | $3.51B |
| Gross Profit (TTM) | $1.14B |
| EBITDA | $605.88M |
| Operating Margin | 13.30% |
| Return on Equity | 9.39% |
| Return on Assets | 5.05% |
| Revenue/Share (TTM) | $64.33 |
| Book Value | $38.72 |
| Price-to-Book | 1.50 |
| Price-to-Sales (TTM) | 0.85 |
| EV/Revenue | 1.448 |
| EV/EBITDA | 9.09 |
| Quarterly Earnings Growth (YoY) | 61.80% |
| Quarterly Revenue Growth (YoY) | 5.80% |
| Shares Outstanding | $53.79M |
| Float | $53.47M |
| % Insiders | 0.28% |
| % Institutions | 109.30% |
Historical Volatility
HV 10-Day
47.76%
HV 20-Day
42.02%
HV 30-Day
40.88%
HV 60-Day
36.85%
HV Rank
78.6%
Volatility is currently expanding
Analyst Ratings
Consensus ($73.29 target)
5
Buy2
HoldLatest News
Is FUL Stock a Buy Now or a Value Trap for Cautious Investors?
FUL trades near the low end of its five-year valuation range as improving earnings meet volume, inflation and leverage risks tied to its medical-market expansion.
Zacks Investment Research7/9/2026Neutral
H.B. Fuller Stock Outlook Hinges on Margins, Mix and M&A
FUL's outlook rests on pricing, margins and portfolio reshaping as medical expansion and M&A aim to offset uneven demand across key end markets.
Zacks Investment Research7/9/2026Positive
FUL vs. PPG: Which Stock Is the Better Value Option?
Investors interested in stocks from the Chemical - Specialty sector have probably already heard of H. B. Fuller (FUL) and PPG Industries (PPG).
Zacks Investment Research7/6/2026Neutral
H.B. Fuller Q2 Earnings Call Flags Pricing, AMS Ambitions
FUL flags stronger pricing, higher profit guidance and a proposed AMS deal aimed at expanding its medical adhesives platform and boosting margins.
Zacks Investment Research6/30/2026Positive
H.B. Fuller: Overreaction, Or Proof Of Slowdown
H.B. Fuller is rated a "buy" with a conservative $80/share price target, reflecting improved fundamentals and recent M&A. FUL's recent results validate earnings recovery: near-6% revenue growth, ~20% AEPS improvement, double-digit EBITDA gains, and record operating cash flow. The AMS acquisition is expected to drive margin expansion, higher-quality revenue, and meaningful revenue and cost synergies, supporting long-term profitability.
Seeking Alpha6/26/2026Neutral
H.B. Fuller Company (FUL) Q2 2026 Earnings Call Transcript
H.B. Fuller Company (FUL) Q2 2026 Earnings Call Transcript
Seeking Alpha6/25/2026Neutral
Ancora Condemns H.B. Fuller's Decision to Ignore Shareholder Opposition and Proceed with the Reckless Acquisition of Advanced Medical Solutions
CLEVELAND--(BUSINESS WIRE)--Ancora Holdings Group, LLC (collectively with its affiliates, “Ancora” or “we”) today released the below statement regarding H.B. Fuller Company (NYSE: FUL) (“H.B. Fuller” or the “Company”) and Advanced Medical Solutions Group plc (“AMS”). Previously, Ancora issued a letter to H.B. Fuller's Board of Directors (the “Board”) regarding its contemplated acquisition of AMS. Fredrick D. DiSanto, Chairman and Chief Executive Officer of Ancora, and James Chadwick, President.
Business Wire6/25/2026Neutral
Advanced Medical Solutions shares jump 16% on £659 million takeover by US adhesives group H.B. Fuller
Shares in Advanced Medical Solutions Group (AIM:AMS) rose 16% to 278.14p after the company agreed to a recommended cash takeover by H.B. Fuller, the US adhesives group, valuing it at about £659 million.
Proactive Investors6/25/2026Positive
H.B. Fuller to buy UK's Advanced Medical Solutions for $942 million
U.S.-based adhesives maker H.B. Fuller will buy Advanced Medical Solutions Group in a cash deal that values the British medical supplier at about £715 million ($942.1 million) including debt, the companies said on Thursday.
Reuters6/25/2026Positive
More BASIC MATERIALS Stocks
Data last updated: 7/9/2026